| Product Name | NebuSelect™ Recombinant Human DR6/TNFRSF21, His-tag |
|---|---|
| Catalog Number | NBL-242735 |
| Alias/Synonyms | DR6/TNFRSF21; Death receptor 6; CD358; TNFRSF21; DR6; BM-018; MGC31965 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | O75509 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242735-100ug | 100ug | Inquire | Inquire | |
| NBL-242735-1mg | 1mg | Inquire | Inquire | |
| NBL-242735-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human DR6/TNFRSF21, His-tag
Catalog#:
NBL-242735
Description:
NebuSelect™ Recombinant Human DR6/TNFRSF21, His-tag(Cat#NBL-242735) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln42-His349.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 34.3 kDa. Due to glycosylation, the protein migrates to 65-80 kDa based on Bis-Tris PAGE result.
Target Name:
DR6/TNFRSF21; Death receptor 6; CD358; TNFRSF21; DR6; BM-018; MGC31965
Target Information:
beta-amyloid precursor protein (APP) and death receptor 6 (DR6, also known as TNFRSF21) activate a widespread caspase-dependent self-destruction program. DR6 is broadly expressed by developing neurons, and is required for normal cell body death and axonal pruning both in vivo and after trophic-factor deprivation in vitro.DR6 is activated locally by an inactive surface ligand(s) that is released in an active form after trophic-factor deprivation.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.